Bartoli M - Search Results

1

Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Among authors: bartoli m. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Mol Ther. 2007. PMID: 17164775 Free article.

2

Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.

Bartoli M, Poupiot J, Goyenvalle A, Perez N, Garcia L, Danos O, Richard I. Bartoli M, et al. Gene Ther. 2006 Jan;13(1):20-8. doi: 10.1038/sj.gt.3302594. Gene Ther. 2006. PMID: 16107863

3

AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.

Bartoli M, Poupiot J, Vulin A, Fougerousse F, Arandel L, Daniele N, Roudaut C, Noulet F, Garcia L, Danos O, Richard I. Bartoli M, et al. Gene Ther. 2007 May;14(9):733-40. doi: 10.1038/sj.gt.3302928. Epub 2007 Mar 1. Gene Ther. 2007. PMID: 17330087

4

Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.

Bartoli M, Roudaut C, Martin S, Fougerousse F, Suel L, Poupiot J, Gicquel E, Noulet F, Danos O, Richard I. Bartoli M, et al. Mol Ther. 2006 Feb;13(2):250-9. doi: 10.1016/j.ymthe.2005.09.017. Epub 2005 Nov 14. Mol Ther. 2006. PMID: 16290124 Free article.

5

Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.

Bartoli M, Gicquel E, Barrault L, Soheili T, Malissen M, Malissen B, Vincent-Lacaze N, Perez N, Udd B, Danos O, Richard I. Bartoli M, et al. Hum Mol Genet. 2008 May 1;17(9):1214-21. doi: 10.1093/hmg/ddn029. Epub 2008 Feb 5. Hum Mol Genet. 2008. PMID: 18252745

6

Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.

Lostal W, Bartoli M, Bourg N, Roudaut C, Bentaïb A, Miyake K, Guerchet N, Fougerousse F, McNeil P, Richard I. Lostal W, et al. Among authors: bartoli m. Hum Mol Genet. 2010 May 15;19(10):1897-907. doi: 10.1093/hmg/ddq065. Epub 2010 Feb 13. Hum Mol Genet. 2010. PMID: 20154340

7

Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Among authors: bartoli m. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Epub 2016 Dec 8. Mol Ther. 2007. PMID: 28182933

8

Calpains in muscle wasting.

Bartoli M, Richard I. Bartoli M, et al. Int J Biochem Cell Biol. 2005 Oct;37(10):2115-33. doi: 10.1016/j.biocel.2004.12.012. Epub 2005 Feb 9. Int J Biochem Cell Biol. 2005. PMID: 16125114 Review.

9

Calpain 3: a key regulator of the sarcomere?

Duguez S, Bartoli M, Richard I. Duguez S, et al. Among authors: bartoli m. FEBS J. 2006 Aug;273(15):3427-36. doi: 10.1111/j.1742-4658.2006.05351.x. FEBS J. 2006. PMID: 16884488 Free article. Review.

10

Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications.

Soheili T, Gicquel E, Poupiot J, N'Guyen L, Le Roy F, Bartoli M, Richard I. Soheili T, et al. Among authors: bartoli m. Hum Mutat. 2012 Feb;33(2):429-39. doi: 10.1002/humu.21659. Epub 2011 Dec 22. Hum Mutat. 2012. PMID: 22095924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters